Neurocrine Biosciences Other Current Assets 2010-2024 | NBIX

Neurocrine Biosciences other current assets for the quarter ending September 30, 2024 were $0.122B, a 12.48% increase year-over-year.

  • Neurocrine Biosciences other current assets for 2023 were $0.098B, a 23.64% increase from 2022.
  • Neurocrine Biosciences other current assets for 2022 were $0.079B, a 73.85% increase from 2021.
  • Neurocrine Biosciences other current assets for 2021 were $0.046B, a 51.16% increase from 2020.

Neurocrine Biosciences Other Current Assets 2010-2024 | NBIX

  • Neurocrine Biosciences other current assets for 2023 were $0.098B, a 23.64% increase from 2022.
  • Neurocrine Biosciences other current assets for 2022 were $0.079B, a 73.85% increase from 2021.
  • Neurocrine Biosciences other current assets for 2021 were $0.046B, a 51.16% increase from 2020.